RankAlpha logo
Back to Rankings

GTLS

Chart IndustriesF
NYSE / Capital Goods
Last Price
At close
2026-07-18
View Chart
Current thesis
Chart converts a large portion of its hydrogen backlog within 12–24 months, supply-chain pressures ease, margins recover, and biopharma/LNG mix expands—making the consensus ~$55 target conservative relative to multi-year revenue visibility [#PR-2025-08-12], [#IR-presentation-Q3-2025].
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.0.
What can break
Project delays, cost overruns, or cancellations push revenue recognition out and compress margins; weaker hydrogen capex or incentive setbacks could force a multiple re-rating until execution is proven [#10-Q-2024-06-30], [#PR-2025-11-05].
Momentum
39
Value
53
Sentiment
0
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $55.00 · Bull $68.75 · Bear $38.25
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-15 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2025-11-14 • Model: RankAlpha Sentiment AI
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $210.00
Why
Momentum39 · Δ7d +1.0
Value53 · Δ7d -0.0
Sentiment0 · Δ7d 0.0
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
39
26% active weight
Current posture
7d trendSoftening
Δ7d
+1.0
Δ21d
+0.8
Value
53
39% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
0
34% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
0.0
Why this grade

Composite grade F. Momentum 39.2 / Value 53.1 / Sentiment 0.0

Fundamentals (TTM)
As of 2026-07-15
Market Cap
$10.05B
Beta
1.75
Shares Out
47.87M
P/E (TTM)
232.0
P/S (TTM)
2.16
P/FCF (TTM)
25.03
Rev YoY
-11.7%
EPS YoY
-137.8%
Gross Margin
+27.8%
Op Margin
+9.8%
Net Debt
$3.31B
Current Ratio
1.53
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology